These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1735771)
21. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients. Ciusani E; Frigerio S; Gelati M; Corsini E; Dufour A; Nespolo A; La Mantia L; Milanese C; Massa G; Salmaggi A J Neuroimmunol; 1998 Feb; 82(1):5-12. PubMed ID: 9526840 [TBL] [Abstract][Full Text] [Related]
22. Intrathecal synthesis of immunosuppressive acidic protein (IAP) in patients with multiple sclerosis and other inflammatory neurological diseases. Seki H; Tsukamoto T; Aso H; Tamura K J Neurol Sci; 1988 Jul; 85(3):259-66. PubMed ID: 3210023 [TBL] [Abstract][Full Text] [Related]
23. Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. Hintzen RQ; van Lier RA; Kuijpers KC; Baars PA; Schaasberg W; Lucas CJ; Polman CH J Neuroimmunol; 1991 Dec; 35(1-3):211-7. PubMed ID: 1659587 [TBL] [Abstract][Full Text] [Related]
24. Intrathecal synthesis of IgM in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation. Sharief MK; Keir G; Thompson EJ J Neurol Sci; 1990 May; 96(2-3):131-42. PubMed ID: 2115907 [TBL] [Abstract][Full Text] [Related]
25. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413 [TBL] [Abstract][Full Text] [Related]
26. Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Ugurel S; Rebmann V; Ferrone S; Tilgen W; Grosse-Wilde H; Reinhold U Cancer; 2001 Jul; 92(2):369-76. PubMed ID: 11466692 [TBL] [Abstract][Full Text] [Related]
27. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity. Minagar A; Adamashvilli I; Jaffe SL; Glabus MF; Gonzalez-Toledo E; Kelley RE Ann N Y Acad Sci; 2005 Jun; 1051():111-20. PubMed ID: 16126950 [TBL] [Abstract][Full Text] [Related]
28. T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients. Scolozzi R; Boccafogli A; Tola MR; Vicentini L; Camerani A; Degani D; Granieri E; Caniatti L; Paolino E J Neurol Sci; 1992 Mar; 108(1):93-8. PubMed ID: 1352538 [TBL] [Abstract][Full Text] [Related]
29. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index. Acar G; Idiman F; Kirkali G; Ozakbaş S; Oktay G; Cakmakçi H; Idiman E J Neurol; 2005 Feb; 252(2):146-50. PubMed ID: 15729518 [TBL] [Abstract][Full Text] [Related]
30. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction. Puppo F; Contini P; Ghio M; Indiveri F ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026 [TBL] [Abstract][Full Text] [Related]
31. Intrathecal origin of CSF ribonuclease. Differences between infectious processes of the nervous system and multiple sclerosis. Allinquant B; Musenger C; Schuller E Acta Neurol Scand; 1984 Jul; 70(1):12-9. PubMed ID: 6206680 [TBL] [Abstract][Full Text] [Related]
32. Soluble HLA in saliva of patients with autoimmune rheumatic diseases. Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679 [TBL] [Abstract][Full Text] [Related]
33. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668 [TBL] [Abstract][Full Text] [Related]
34. Intrathecal synthesis in particular types of multiple sclerosis. Sladkova V; Mares J; Hlustik P; Langova J; Kanovsky P Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):124-6. PubMed ID: 23073520 [TBL] [Abstract][Full Text] [Related]
35. [Expression of interleukin 2 receptor and class II histocompatibility antigens on lymphocytes of the cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases]. Tournier-Lasserve E; Lyon-Caen O; Roullet E; Bach MA Pathol Biol (Paris); 1987 Mar; 35(3):303-6. PubMed ID: 3108835 [TBL] [Abstract][Full Text] [Related]
36. A sensitive time-resolved immunofluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Application to multiple sclerosis and other neurological diseases. Osman I; Gaillard O; Meillet D; Bordas-Fonfrède M; Gervais A; Schuller E; Delattre J; Legrand A Eur J Clin Chem Clin Biochem; 1995 Jan; 33(1):53-8. PubMed ID: 7756441 [TBL] [Abstract][Full Text] [Related]
37. Alpha 1-antitrypsin in cerebrospinal fluid of patients with neurologic diseases. Pearl GS; Mullins RE Arch Neurol; 1985 Aug; 42(8):775-7. PubMed ID: 3875332 [TBL] [Abstract][Full Text] [Related]
38. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Link H; Tibbling G Scand J Clin Lab Invest; 1977 Sep; 37(5):397-401. PubMed ID: 337461 [TBL] [Abstract][Full Text] [Related]
39. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution. Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282 [TBL] [Abstract][Full Text] [Related]
40. Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Tsuchiya N; Shiota M; Yamaguchi A; Ito K Arthritis Rheum; 1996 May; 39(5):792-6. PubMed ID: 8639176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]